Polidocanol 1% and Steroid in Keloids and Hypertrophic Scars
ConditionKeloid and Hypertrophic Scars
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-60
SponsorSohag University
About this trial
we will inject intralesional polidocanol 1% in keloids and hypertrophic scars to decrease vascularity and decrease size of lesion compared to intralesional steroid as standard treatment line
Eligibility criteria
Qualifiers
None
Disqualifiers
Pregnancy, lactation.
Skin lesions, infection in the injection area.
Patients with systemic disease (diabetes mellitus, heart disease, cancer, mental illness).
Allergy to substances used.
Trial design
Treatments tested in this trial
- Group 1 (polidocanol 1% group):
- Group 2 (Triamcinolone acetonide group):
- Group 3 (combined Triamcinolone acetonide and polidocanol 1% group):
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov